经济激励对患者决定接受低价值头部CT扫描的影响
本研究为密歇根大学急诊科开展的横断面调查,纳入913例患者,采用假设性轻度创伤性颅脑损伤情景。向参与者提供头部CT检测脑出血的获益信息(0.1%或1%)、致癌风险信息(0.1%或1%)以及0或100美元放弃检查的激励。主要结局为患者选择接受检查的偏好。结果显示,检测获益从0.1%升至1%显著增加检查接受度(AOR=1.6,95%CI=1.2-2.1),风险从0.1%升至1%显著降低接受度(AOR=0.70,95%CI=0.52-0.93),100美元激励显著降低接受度(AOR=0.6,95%CI=0.4-0.8)。作者指出该研究为初步和假设性,需在面临实际决策的更大患者队列中确认。
要点
- 在假设性轻度创伤性颅脑损伤急诊情景中,提供100美元放弃低价值头部CT的激励显著降低患者检查接受度(AOR=0.6,95%CI=0.4-0.8)。
- 检测获益从0.1%提高至1%显著增加检查接受度(AOR=1.6,95%CI=1.2-2.1),提示获益信息影响患者决策。
- 检测风险从0.1%提高至1%显著降低检查接受度(AOR=0.70,95%CI=0.52-0.93),提示风险信息同样影响决策。
- 该研究为横断面调查,采用假设性情景,结论需在面临实际决策的更大患者队列中确认。
适用人群与场景
- 密歇根大学急诊科就诊的患者,参与假设性轻度创伤性颅脑损伤后急诊就诊情景调查。
研究设计与关键结果
- 研究类型为横断面调查,样本量913例患者,单中心(密歇根大学急诊科),人群为急诊就诊患者,干预为提供检测获益(0.1%或1%)、风险(0.1%或1%)信息及0或100美元放弃检查激励,主要终点为患者选择接受检查的偏好。
- 检测获益从0.1%升至1%显著增加检查接受度(AOR=1.6,95%CI=1.2-2.1)。
- 检测风险从0.1%升至1%显著降低检查接受度(AOR=0.70,95%CI=0.52-0.93)。
- 100美元激励放弃低价值检查显著降低检查接受度(AOR=0.6,95%CI=0.4-0.8)。
证据类型、等级与局限
- 证据类型为横断面调查。
- 局限:作者指出该研究为初步和假设性,需在面临实际决策的更大患者队列中确认。
对床旁实践的改变
- 作者认为提供经济激励以放弃检查可显著降低患者对低价值头部CT的偏好,即使在校正检测获益和风险后仍成立。
- 作者指出该工作为初步和假设性,需在面临实际决策的更大患者队列中确认。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Excessive diagnostic testing and defensive medicine contribute to billions of dollars in avoidable costs in the United States annually. Our objective was to determine the influence of financial incentives, accompanied with information regarding test risk and benefit, on patient preference for diagnostic testing.
METHODS: We conducted a cross-sectional survey of patients at the University of Michigan emergency department (ED). Each participant was presented with a hypothetical scenario involving an ED visit following minor traumatic brain injury. Participants were given information regarding potential benefit (detecting brain hemorrhage) and risk (developing cancer) of head computed tomography scan, as well as an incentive of $0 or $100 to forego testing. We used 0.1 and 1% for test benefit and risk, and values for risk, benefit, and financial incentive varied across participants. Our primary outcome was patient preference to undergo testing. We also collected demographic and numeracy information. We then used logistic regression to estimate odds ratios (ORs), which were adjusted for multiple potential confounders. Our sample size was designed to find at least 300 events (preference for testing) to allow for inclusion of up to 30 covariates in fully adjusted models. We had 85% to 90% power to detect a 10% absolute difference in testing rate across groups, assuming a 95% significance level.
RESULTS: We surveyed 913 patients. Increasing test benefit from 0.1% to 1% significantly increased test acceptance (adjusted OR [AOR] = 1.6, 95% confidence interval [CI] = 1.2 to 2.1) and increasing test risk from 0.1% to 1% significantly decreased test acceptance (AOR = 0.70, 95% CI = 0.52 to 0.93). Finally, a $100 incentive to forego low-value testing significantly reduced test acceptance (AOR = 0.6; 95% CI = 0.4 to 0.8).
CONCLUSIONS: Providing financial incentives to forego testing significantly decreased patient preference for testing, even when accounting for test benefit and risk. This work is preliminary and hypothetical and requires confirmation in larger patient cohorts facing these actual decisions.
参考来源
- Iyengar R, Winkels JL, Smith CM, et al. The Effect of Financial Incentives on Patient Decisions to Undergo Low-value Head Computed Tomography Scans. Acad Emerg Med. 2019. PMID: 31535430. doi:10.1111/acem.13823
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。